Mindset Pharma Inc.: Mindset Pharma Announces Upsizing and Closing of $4.17 Million Brokered Private Placement Financing
Mindset or the
Company ), a drug discovery and development company focused on developing next generation psychedelic medicines for the treatment of neuropsychiatric and neurological indications with unmet needs, is pleased to announce that it has upsized and completed its previously announced brokered private placement, led by Mackie Research Capital Corporation, as sole agent and sole bookrunner (the
Agent ), pursuant to which the Company issued an aggregate of 10,428,813 units (a
Unit ) of the Company at a price of $0.40 per Unit (the
Offering Price ) for aggregate gross proceeds of $4,171,525.20, including the full exercise of the over-allotment option (the